TY - JOUR
T1 - A Review of Posteromedial Lesions of the ChestWall
T2 - What Should a Chest Radiologist Know?
AU - Haseli, Sara
AU - Mansoori, Bahar
AU - Shafiei, Mehrzad
AU - Zadeh, Firoozeh Shomal
AU - Chalian, Hamid
AU - Khoshpouri, Parisa
AU - Yousem, David
AU - Chalian, Majid
N1 - Publisher Copyright:
© 2022 by the authors.
PY - 2022/2
Y1 - 2022/2
N2 - A heterogeneous group of tumors can affect the posteromedial chest wall. They form diverse groups of benign and malignant (primary or secondary) pathologies that can arise from different chest wall structures, i.e., fat, muscular, vascular, osseous, or neurogenic tissues. Chest radiography is very nonspecific for the characterization of chest wall lesions. The modality of choice for the initial assessment of the chest wall lesions is computed tomography (CT). More advanced cross-sectional modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET) with fluorodeoxyglucose are usually used for further characterization, staging, treatment response, and assessment of recurrence. A systematic approach based on age, clinical history, and radiologic findings is required for correct diagnosis. It is essential for radiologists to be familiar with the spectrum of lesions that might affect the posteromedial chest wall and their characteristic imaging features. Although the imaging findings of these tumors can be nonspecific, cross-sectional imaging helps to limit the differential diagnosis and determine the further diagnostic investigation (e.g., image-guided biopsy). Specific imaging findings, e.g., location, mineralization, enhancement pattern, and local invasion, occasionally allow a particular diagnosis. This article reviews the posteromedial chest wall anatomy and different pathologies. We provide a combination of location and imaging features of each pathology. We will also explore the role of imaging and its strengths and limitations for diagnosing posteromedial chest wall lesions.
AB - A heterogeneous group of tumors can affect the posteromedial chest wall. They form diverse groups of benign and malignant (primary or secondary) pathologies that can arise from different chest wall structures, i.e., fat, muscular, vascular, osseous, or neurogenic tissues. Chest radiography is very nonspecific for the characterization of chest wall lesions. The modality of choice for the initial assessment of the chest wall lesions is computed tomography (CT). More advanced cross-sectional modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET) with fluorodeoxyglucose are usually used for further characterization, staging, treatment response, and assessment of recurrence. A systematic approach based on age, clinical history, and radiologic findings is required for correct diagnosis. It is essential for radiologists to be familiar with the spectrum of lesions that might affect the posteromedial chest wall and their characteristic imaging features. Although the imaging findings of these tumors can be nonspecific, cross-sectional imaging helps to limit the differential diagnosis and determine the further diagnostic investigation (e.g., image-guided biopsy). Specific imaging findings, e.g., location, mineralization, enhancement pattern, and local invasion, occasionally allow a particular diagnosis. This article reviews the posteromedial chest wall anatomy and different pathologies. We provide a combination of location and imaging features of each pathology. We will also explore the role of imaging and its strengths and limitations for diagnosing posteromedial chest wall lesions.
KW - Benign
KW - Chest wall
KW - Imaging
KW - Lesion
KW - Malignant
KW - Posteromedial
UR - http://www.scopus.com/inward/record.url?scp=85124472664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124472664&partnerID=8YFLogxK
U2 - 10.3390/diagnostics12020301
DO - 10.3390/diagnostics12020301
M3 - Article
C2 - 35204391
AN - SCOPUS:85124472664
SN - 2075-4418
VL - 12
JO - Diagnostics
JF - Diagnostics
IS - 2
M1 - 301
ER -